Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Elser

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Cancer Research Communications|June 28, 2023
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni SyndromeVallijah Subasri, Nicholas Light, Nisha Kanwar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2022
Impact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults With Cancer: The Randomized 5C TrialMartine Puts, Naser Alqurini, Fay Strohschein, et al.
BMJ Open|April 29, 2022
Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service deliverySalma Shickh, Daena Hirjikaka, Marc Clausen, et al.
BMJ Open|May 13, 2019
Clinical and Cost-effectiveness of a Comprehensive geriatric assessment and management for Canadian elders with Cancer-the 5C study: a study protocol for a randomised controlled phase III trialMartine T E Puts, Tina Hsu, Caroline Mariano, et al.
BMJ Open|October 10, 2019
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer SusceptibilityNardin Samuel, Gavin Wilson, Mathieu Lemire, et al.
BMJ (Clinical Research Ed.)|December 9, 2021
Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trialMonika K Krzyzanowska, Jim A Julian, Chu-Shu Gu, et al.
Genetics in Medicine Open|December 13, 2024
Genetics Adviser: The development and usability testing of a new patient digital health application to support clinical genomic testingMarc Clausen, Suvetha Krishnapillai, Daena Hirjikaka, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 12, 2019
Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trialYvonne Bombard, Marc Clausen, Salma Shickh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 12, 2024
Opportunistic genomic screening has clinical utility: An interventional cohort studyChloe Mighton, Rita Kodida, Salma Shickh, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Cancer Research Communications|June 28, 2023
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni SyndromeVallijah Subasri, Nicholas Light, Nisha Kanwar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2022
Impact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults With Cancer: The Randomized 5C TrialMartine Puts, Naser Alqurini, Fay Strohschein, et al.
BMJ Open|April 29, 2022
Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service deliverySalma Shickh, Daena Hirjikaka, Marc Clausen, et al.
BMJ Open|May 13, 2019
Clinical and Cost-effectiveness of a Comprehensive geriatric assessment and management for Canadian elders with Cancer-the 5C study: a study protocol for a randomised controlled phase III trialMartine T E Puts, Tina Hsu, Caroline Mariano, et al.
BMJ Open|October 10, 2019
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer SusceptibilityNardin Samuel, Gavin Wilson, Mathieu Lemire, et al.
BMJ (Clinical Research Ed.)|December 9, 2021
Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trialMonika K Krzyzanowska, Jim A Julian, Chu-Shu Gu, et al.
Genetics in Medicine Open|December 13, 2024
Genetics Adviser: The development and usability testing of a new patient digital health application to support clinical genomic testingMarc Clausen, Suvetha Krishnapillai, Daena Hirjikaka, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 12, 2019
Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trialYvonne Bombard, Marc Clausen, Salma Shickh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 12, 2024
Opportunistic genomic screening has clinical utility: An interventional cohort studyChloe Mighton, Rita Kodida, Salma Shickh, et al.
Pageof 5